nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—Osteoarthritis—Epirubicin—liver cancer	0.000685	0.00121	CcSEcCtD
Bexarotene—Increased appetite—Doxorubicin—liver cancer	0.000675	0.00119	CcSEcCtD
Bexarotene—Migraine—Epirubicin—liver cancer	0.000674	0.00119	CcSEcCtD
Bexarotene—Affect lability—Epirubicin—liver cancer	0.000674	0.00119	CcSEcCtD
Bexarotene—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000672	0.00119	CcSEcCtD
Bexarotene—Hypersensitivity—Sorafenib—liver cancer	0.000671	0.00119	CcSEcCtD
Bexarotene—Renal impairment—Doxorubicin—liver cancer	0.000666	0.00118	CcSEcCtD
Bexarotene—Dermatitis bullous—Doxorubicin—liver cancer	0.000663	0.00117	CcSEcCtD
Bexarotene—Face oedema—Epirubicin—liver cancer	0.000662	0.00117	CcSEcCtD
Bexarotene—Purpura—Doxorubicin—liver cancer	0.000658	0.00116	CcSEcCtD
Bexarotene—Asthenia—Sorafenib—liver cancer	0.000654	0.00116	CcSEcCtD
Bexarotene—Mood swings—Epirubicin—liver cancer	0.000649	0.00115	CcSEcCtD
Bexarotene—Lethargy—Doxorubicin—liver cancer	0.000647	0.00114	CcSEcCtD
Bexarotene—Cerebrovascular accident—Doxorubicin—liver cancer	0.000647	0.00114	CcSEcCtD
Bexarotene—Pruritus—Sorafenib—liver cancer	0.000645	0.00114	CcSEcCtD
Bexarotene—Ataxia—Epirubicin—liver cancer	0.000644	0.00114	CcSEcCtD
Bexarotene—Blood creatinine increased—Epirubicin—liver cancer	0.000642	0.00114	CcSEcCtD
Bexarotene—Dehydration—Epirubicin—liver cancer	0.000637	0.00113	CcSEcCtD
Bexarotene—Hyponatraemia—Doxorubicin—liver cancer	0.000637	0.00113	CcSEcCtD
Bexarotene—Osteoarthritis—Doxorubicin—liver cancer	0.000634	0.00112	CcSEcCtD
Bexarotene—Liver function test abnormal—Epirubicin—liver cancer	0.000633	0.00112	CcSEcCtD
Bexarotene—Dry skin—Epirubicin—liver cancer	0.000628	0.00111	CcSEcCtD
Bexarotene—Affect lability—Doxorubicin—liver cancer	0.000624	0.0011	CcSEcCtD
Bexarotene—Migraine—Doxorubicin—liver cancer	0.000624	0.0011	CcSEcCtD
Bexarotene—Hypokalaemia—Epirubicin—liver cancer	0.000624	0.0011	CcSEcCtD
Bexarotene—Diarrhoea—Sorafenib—liver cancer	0.000623	0.0011	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000617	0.00109	CcSEcCtD
Bexarotene—Face oedema—Doxorubicin—liver cancer	0.000612	0.00108	CcSEcCtD
Bexarotene—Muscular weakness—Epirubicin—liver cancer	0.000604	0.00107	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000604	0.00107	CcSEcCtD
Bexarotene—Dizziness—Sorafenib—liver cancer	0.000603	0.00107	CcSEcCtD
Bexarotene—Mood swings—Doxorubicin—liver cancer	0.000601	0.00106	CcSEcCtD
Bexarotene—Abdominal distension—Epirubicin—liver cancer	0.000596	0.00105	CcSEcCtD
Bexarotene—Ataxia—Doxorubicin—liver cancer	0.000596	0.00105	CcSEcCtD
Bexarotene—Blood creatinine increased—Doxorubicin—liver cancer	0.000594	0.00105	CcSEcCtD
Bexarotene—Influenza—Epirubicin—liver cancer	0.000592	0.00105	CcSEcCtD
Bexarotene—Dysphagia—Epirubicin—liver cancer	0.000592	0.00105	CcSEcCtD
Bexarotene—Dehydration—Doxorubicin—liver cancer	0.00059	0.00104	CcSEcCtD
Bexarotene—Eosinophilia—Epirubicin—liver cancer	0.000586	0.00104	CcSEcCtD
Bexarotene—Liver function test abnormal—Doxorubicin—liver cancer	0.000585	0.00104	CcSEcCtD
Bexarotene—Dry skin—Doxorubicin—liver cancer	0.000581	0.00103	CcSEcCtD
Bexarotene—Pancreatitis—Epirubicin—liver cancer	0.000581	0.00103	CcSEcCtD
Bexarotene—Vomiting—Sorafenib—liver cancer	0.000579	0.00102	CcSEcCtD
Bexarotene—Hypokalaemia—Doxorubicin—liver cancer	0.000577	0.00102	CcSEcCtD
Bexarotene—Angina pectoris—Epirubicin—liver cancer	0.000577	0.00102	CcSEcCtD
Bexarotene—Rash—Sorafenib—liver cancer	0.000575	0.00102	CcSEcCtD
Bexarotene—Dermatitis—Sorafenib—liver cancer	0.000574	0.00102	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000571	0.00101	CcSEcCtD
Bexarotene—Headache—Sorafenib—liver cancer	0.000571	0.00101	CcSEcCtD
Bexarotene—Bronchitis—Epirubicin—liver cancer	0.00057	0.00101	CcSEcCtD
Bexarotene—Pancytopenia—Epirubicin—liver cancer	0.000562	0.000995	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000559	0.000989	CcSEcCtD
Bexarotene—Muscular weakness—Doxorubicin—liver cancer	0.000559	0.000989	CcSEcCtD
Bexarotene—Dysuria—Epirubicin—liver cancer	0.000554	0.000979	CcSEcCtD
Bexarotene—Neutropenia—Epirubicin—liver cancer	0.000554	0.000979	CcSEcCtD
Bexarotene—Abdominal distension—Doxorubicin—liver cancer	0.000552	0.000976	CcSEcCtD
Bexarotene—Influenza—Doxorubicin—liver cancer	0.000548	0.000969	CcSEcCtD
Bexarotene—Dysphagia—Doxorubicin—liver cancer	0.000548	0.000969	CcSEcCtD
Bexarotene—Pollakiuria—Epirubicin—liver cancer	0.000547	0.000968	CcSEcCtD
Bexarotene—Eosinophilia—Doxorubicin—liver cancer	0.000543	0.00096	CcSEcCtD
Bexarotene—Nausea—Sorafenib—liver cancer	0.000541	0.000957	CcSEcCtD
Bexarotene—Photosensitivity reaction—Epirubicin—liver cancer	0.000541	0.000956	CcSEcCtD
Bexarotene—Weight increased—Epirubicin—liver cancer	0.000539	0.000953	CcSEcCtD
Bexarotene—Pancreatitis—Doxorubicin—liver cancer	0.000537	0.00095	CcSEcCtD
Bexarotene—Weight decreased—Epirubicin—liver cancer	0.000536	0.000948	CcSEcCtD
Bexarotene—Hyperglycaemia—Epirubicin—liver cancer	0.000534	0.000945	CcSEcCtD
Bexarotene—Angina pectoris—Doxorubicin—liver cancer	0.000534	0.000944	CcSEcCtD
Bexarotene—Pneumonia—Epirubicin—liver cancer	0.000531	0.000939	CcSEcCtD
Bexarotene—Bronchitis—Doxorubicin—liver cancer	0.000527	0.000932	CcSEcCtD
Bexarotene—Pancytopenia—Doxorubicin—liver cancer	0.00052	0.00092	CcSEcCtD
Bexarotene—Neuropathy peripheral—Epirubicin—liver cancer	0.000518	0.000915	CcSEcCtD
Bexarotene—Stomatitis—Epirubicin—liver cancer	0.000515	0.00091	CcSEcCtD
Bexarotene—Jaundice—Epirubicin—liver cancer	0.000515	0.00091	CcSEcCtD
Bexarotene—Conjunctivitis—Epirubicin—liver cancer	0.000513	0.000908	CcSEcCtD
Bexarotene—Urinary tract infection—Epirubicin—liver cancer	0.000513	0.000908	CcSEcCtD
Bexarotene—Neutropenia—Doxorubicin—liver cancer	0.000512	0.000906	CcSEcCtD
Bexarotene—Dysuria—Doxorubicin—liver cancer	0.000512	0.000906	CcSEcCtD
Bexarotene—Sweating—Epirubicin—liver cancer	0.000506	0.000895	CcSEcCtD
Bexarotene—Pollakiuria—Doxorubicin—liver cancer	0.000506	0.000895	CcSEcCtD
Bexarotene—Haematuria—Epirubicin—liver cancer	0.000503	0.00089	CcSEcCtD
Bexarotene—Photosensitivity reaction—Doxorubicin—liver cancer	0.0005	0.000885	CcSEcCtD
Bexarotene—Weight increased—Doxorubicin—liver cancer	0.000499	0.000882	CcSEcCtD
Bexarotene—Epistaxis—Epirubicin—liver cancer	0.000498	0.000881	CcSEcCtD
Bexarotene—Weight decreased—Doxorubicin—liver cancer	0.000496	0.000877	CcSEcCtD
Bexarotene—Sinusitis—Epirubicin—liver cancer	0.000495	0.000876	CcSEcCtD
Bexarotene—Hyperglycaemia—Doxorubicin—liver cancer	0.000494	0.000874	CcSEcCtD
Bexarotene—Pneumonia—Doxorubicin—liver cancer	0.000491	0.000869	CcSEcCtD
Bexarotene—Neuropathy peripheral—Doxorubicin—liver cancer	0.000479	0.000847	CcSEcCtD
Bexarotene—Haemoglobin—Epirubicin—liver cancer	0.000476	0.000843	CcSEcCtD
Bexarotene—Jaundice—Doxorubicin—liver cancer	0.000476	0.000842	CcSEcCtD
Bexarotene—Stomatitis—Doxorubicin—liver cancer	0.000476	0.000842	CcSEcCtD
Bexarotene—Rhinitis—Epirubicin—liver cancer	0.000475	0.000841	CcSEcCtD
Bexarotene—Urinary tract infection—Doxorubicin—liver cancer	0.000475	0.00084	CcSEcCtD
Bexarotene—Conjunctivitis—Doxorubicin—liver cancer	0.000475	0.00084	CcSEcCtD
Bexarotene—Haemorrhage—Epirubicin—liver cancer	0.000474	0.000838	CcSEcCtD
Bexarotene—Hypoaesthesia—Epirubicin—liver cancer	0.000472	0.000834	CcSEcCtD
Bexarotene—Pharyngitis—Epirubicin—liver cancer	0.00047	0.000832	CcSEcCtD
Bexarotene—Sweating—Doxorubicin—liver cancer	0.000468	0.000828	CcSEcCtD
Bexarotene—Urinary tract disorder—Epirubicin—liver cancer	0.000468	0.000828	CcSEcCtD
Bexarotene—Oedema peripheral—Epirubicin—liver cancer	0.000467	0.000826	CcSEcCtD
Bexarotene—Haematuria—Doxorubicin—liver cancer	0.000466	0.000824	CcSEcCtD
Bexarotene—Connective tissue disorder—Epirubicin—liver cancer	0.000466	0.000824	CcSEcCtD
Bexarotene—Urethral disorder—Epirubicin—liver cancer	0.000465	0.000822	CcSEcCtD
Bexarotene—Epistaxis—Doxorubicin—liver cancer	0.000461	0.000815	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—liver cancer	0.000458	0.000811	CcSEcCtD
Bexarotene—Eye disorder—Epirubicin—liver cancer	0.000443	0.000784	CcSEcCtD
Bexarotene—Tinnitus—Epirubicin—liver cancer	0.000442	0.000782	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—liver cancer	0.000441	0.00078	CcSEcCtD
Bexarotene—Cardiac disorder—Epirubicin—liver cancer	0.00044	0.000778	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—liver cancer	0.00044	0.000778	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—liver cancer	0.000439	0.000776	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—liver cancer	0.000436	0.000772	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—liver cancer	0.000435	0.00077	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—liver cancer	0.000433	0.000766	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—liver cancer	0.000432	0.000764	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—liver cancer	0.000431	0.000762	CcSEcCtD
Bexarotene—Angiopathy—Epirubicin—liver cancer	0.00043	0.000761	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—liver cancer	0.00043	0.00076	CcSEcCtD
Bexarotene—Chills—Epirubicin—liver cancer	0.000425	0.000752	CcSEcCtD
Bexarotene—Arrhythmia—Epirubicin—liver cancer	0.000423	0.000749	CcSEcCtD
Bexarotene—Alopecia—Epirubicin—liver cancer	0.000419	0.000741	CcSEcCtD
Bexarotene—Erythema—Epirubicin—liver cancer	0.000413	0.00073	CcSEcCtD
Bexarotene—Malnutrition—Epirubicin—liver cancer	0.000413	0.00073	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—liver cancer	0.00041	0.000725	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—liver cancer	0.000409	0.000723	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—liver cancer	0.000407	0.00072	CcSEcCtD
Bexarotene—Flatulence—Epirubicin—liver cancer	0.000407	0.000719	CcSEcCtD
Bexarotene—Tension—Epirubicin—liver cancer	0.000405	0.000716	CcSEcCtD
Bexarotene—Dysgeusia—Epirubicin—liver cancer	0.000404	0.000715	CcSEcCtD
Bexarotene—Nervousness—Epirubicin—liver cancer	0.000401	0.000709	CcSEcCtD
Bexarotene—Back pain—Epirubicin—liver cancer	0.000399	0.000706	CcSEcCtD
Bexarotene—Angiopathy—Doxorubicin—liver cancer	0.000398	0.000704	CcSEcCtD
Bexarotene—Muscle spasms—Epirubicin—liver cancer	0.000397	0.000702	CcSEcCtD
Bexarotene—Chills—Doxorubicin—liver cancer	0.000394	0.000696	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—liver cancer	0.000392	0.000693	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—liver cancer	0.000388	0.000686	CcSEcCtD
Bexarotene—Ill-defined disorder—Epirubicin—liver cancer	0.000383	0.000677	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—liver cancer	0.000382	0.000675	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—liver cancer	0.000382	0.000675	CcSEcCtD
Bexarotene—Anaemia—Epirubicin—liver cancer	0.000381	0.000675	CcSEcCtD
Bexarotene—Agitation—Epirubicin—liver cancer	0.000379	0.000671	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—liver cancer	0.000376	0.000665	CcSEcCtD
Bexarotene—Tension—Doxorubicin—liver cancer	0.000375	0.000663	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—liver cancer	0.000374	0.000661	CcSEcCtD
Bexarotene—Malaise—Epirubicin—liver cancer	0.000372	0.000658	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—liver cancer	0.000371	0.000656	CcSEcCtD
Bexarotene—Vertigo—Epirubicin—liver cancer	0.000371	0.000656	CcSEcCtD
Bexarotene—Syncope—Epirubicin—liver cancer	0.00037	0.000655	CcSEcCtD
Bexarotene—Leukopenia—Epirubicin—liver cancer	0.000369	0.000653	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—liver cancer	0.000369	0.000653	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—liver cancer	0.000367	0.000649	CcSEcCtD
Bexarotene—Palpitations—Epirubicin—liver cancer	0.000365	0.000645	CcSEcCtD
Bexarotene—Loss of consciousness—Epirubicin—liver cancer	0.000363	0.000641	CcSEcCtD
Bexarotene—Cough—Epirubicin—liver cancer	0.00036	0.000637	CcSEcCtD
Bexarotene—Hypertension—Epirubicin—liver cancer	0.000356	0.00063	CcSEcCtD
Bexarotene—Ill-defined disorder—Doxorubicin—liver cancer	0.000354	0.000627	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—liver cancer	0.000353	0.000624	CcSEcCtD
Bexarotene—Arthralgia—Epirubicin—liver cancer	0.000351	0.000621	CcSEcCtD
Bexarotene—Myalgia—Epirubicin—liver cancer	0.000351	0.000621	CcSEcCtD
Bexarotene—Chest pain—Epirubicin—liver cancer	0.000351	0.000621	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—liver cancer	0.000351	0.000621	CcSEcCtD
Bexarotene—Anxiety—Epirubicin—liver cancer	0.00035	0.000619	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000349	0.000617	CcSEcCtD
Bexarotene—Discomfort—Epirubicin—liver cancer	0.000347	0.000614	CcSEcCtD
Bexarotene—Malaise—Doxorubicin—liver cancer	0.000344	0.000609	CcSEcCtD
Bexarotene—Dry mouth—Epirubicin—liver cancer	0.000344	0.000608	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—liver cancer	0.000343	0.000607	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—liver cancer	0.000342	0.000606	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—liver cancer	0.000342	0.000604	CcSEcCtD
Bexarotene—Confusional state—Epirubicin—liver cancer	0.00034	0.000601	CcSEcCtD
Bexarotene—Palpitations—Doxorubicin—liver cancer	0.000337	0.000597	CcSEcCtD
Bexarotene—Oedema—Epirubicin—liver cancer	0.000337	0.000596	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—liver cancer	0.000336	0.000594	CcSEcCtD
Bexarotene—Infection—Epirubicin—liver cancer	0.000335	0.000592	CcSEcCtD
Bexarotene—Cough—Doxorubicin—liver cancer	0.000333	0.000589	CcSEcCtD
Bexarotene—Shock—Epirubicin—liver cancer	0.000331	0.000586	CcSEcCtD
Bexarotene—Nervous system disorder—Epirubicin—liver cancer	0.00033	0.000584	CcSEcCtD
Bexarotene—Thrombocytopenia—Epirubicin—liver cancer	0.00033	0.000583	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—liver cancer	0.00033	0.000583	CcSEcCtD
Bexarotene—Tachycardia—Epirubicin—liver cancer	0.000329	0.000581	CcSEcCtD
Bexarotene—Skin disorder—Epirubicin—liver cancer	0.000327	0.000579	CcSEcCtD
Bexarotene—Hyperhidrosis—Epirubicin—liver cancer	0.000326	0.000576	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—liver cancer	0.000325	0.000575	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—liver cancer	0.000325	0.000575	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—liver cancer	0.000325	0.000575	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—liver cancer	0.000324	0.000573	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000323	0.000571	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—liver cancer	0.000321	0.000568	CcSEcCtD
Bexarotene—Anorexia—Epirubicin—liver cancer	0.000321	0.000568	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—liver cancer	0.000318	0.000562	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—liver cancer	0.000314	0.000556	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—liver cancer	0.000312	0.000551	CcSEcCtD
Bexarotene—Infection—Doxorubicin—liver cancer	0.00031	0.000548	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000307	0.000543	CcSEcCtD
Bexarotene—Shock—Doxorubicin—liver cancer	0.000307	0.000542	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—liver cancer	0.000306	0.000541	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—liver cancer	0.000305	0.00054	CcSEcCtD
Bexarotene—Insomnia—Epirubicin—liver cancer	0.000305	0.000539	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—liver cancer	0.000304	0.000538	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—liver cancer	0.000303	0.000535	CcSEcCtD
Bexarotene—Paraesthesia—Epirubicin—liver cancer	0.000302	0.000535	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—liver cancer	0.000301	0.000533	CcSEcCtD
Bexarotene—Dyspnoea—Epirubicin—liver cancer	0.0003	0.000531	CcSEcCtD
Bexarotene—Somnolence—Epirubicin—liver cancer	0.000299	0.00053	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—liver cancer	0.000297	0.000525	CcSEcCtD
Bexarotene—Dyspepsia—Epirubicin—liver cancer	0.000296	0.000524	CcSEcCtD
Bexarotene—Decreased appetite—Epirubicin—liver cancer	0.000293	0.000518	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Epirubicin—liver cancer	0.000291	0.000514	CcSEcCtD
Bexarotene—Fatigue—Epirubicin—liver cancer	0.00029	0.000514	CcSEcCtD
Bexarotene—Pain—Epirubicin—liver cancer	0.000288	0.000509	CcSEcCtD
Bexarotene—Constipation—Epirubicin—liver cancer	0.000288	0.000509	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000284	0.000502	CcSEcCtD
Bexarotene—Insomnia—Doxorubicin—liver cancer	0.000282	0.000498	CcSEcCtD
Bexarotene—Paraesthesia—Doxorubicin—liver cancer	0.00028	0.000495	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—liver cancer	0.000278	0.000491	CcSEcCtD
Bexarotene—Feeling abnormal—Epirubicin—liver cancer	0.000278	0.000491	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—liver cancer	0.000277	0.00049	CcSEcCtD
Bexarotene—Gastrointestinal pain—Epirubicin—liver cancer	0.000275	0.000487	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—liver cancer	0.000274	0.000485	CcSEcCtD
Bexarotene—Decreased appetite—Doxorubicin—liver cancer	0.000271	0.000479	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000269	0.000476	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—liver cancer	0.000269	0.000475	CcSEcCtD
Bexarotene—Pain—Doxorubicin—liver cancer	0.000266	0.000471	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—liver cancer	0.000266	0.000471	CcSEcCtD
Bexarotene—Body temperature increased—Epirubicin—liver cancer	0.000266	0.000471	CcSEcCtD
Bexarotene—Abdominal pain—Epirubicin—liver cancer	0.000266	0.000471	CcSEcCtD
Bexarotene—Feeling abnormal—Doxorubicin—liver cancer	0.000257	0.000454	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—liver cancer	0.000255	0.000451	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000249	0.000573	CbGpPWpGaD
Bexarotene—Hypersensitivity—Epirubicin—liver cancer	0.000248	0.000439	CcSEcCtD
Bexarotene—Body temperature increased—Doxorubicin—liver cancer	0.000246	0.000436	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—liver cancer	0.000246	0.000436	CcSEcCtD
Bexarotene—RXRG—Gene Expression—PSMA4—liver cancer	0.000242	0.000557	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PSMD10—liver cancer	0.000242	0.000557	CbGpPWpGaD
Bexarotene—Asthenia—Epirubicin—liver cancer	0.000242	0.000427	CcSEcCtD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000241	0.000555	CbGpPWpGaD
Bexarotene—Pruritus—Epirubicin—liver cancer	0.000238	0.000421	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.000237	0.000545	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TAT—liver cancer	0.000236	0.000543	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CTNNB1—liver cancer	0.000236	0.000543	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—liver cancer	0.000235	0.00054	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000232	0.000534	CbGpPWpGaD
Bexarotene—Diarrhoea—Epirubicin—liver cancer	0.00023	0.000408	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—CDKN1A—liver cancer	0.00023	0.00053	CbGpPWpGaD
Bexarotene—Hypersensitivity—Doxorubicin—liver cancer	0.00023	0.000406	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000229	0.000526	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PSMA4—liver cancer	0.000228	0.000524	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PSMD10—liver cancer	0.000228	0.000524	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.000226	0.00052	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—SERPINE1—liver cancer	0.000225	0.000518	CbGpPWpGaD
Bexarotene—Asthenia—Doxorubicin—liver cancer	0.000224	0.000395	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000223	0.000513	CbGpPWpGaD
Bexarotene—Dizziness—Epirubicin—liver cancer	0.000223	0.000394	CcSEcCtD
Bexarotene—Pruritus—Doxorubicin—liver cancer	0.00022	0.00039	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000219	0.000504	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000216	0.000497	CbGpPWpGaD
Bexarotene—Vomiting—Epirubicin—liver cancer	0.000214	0.000379	CcSEcCtD
Bexarotene—Diarrhoea—Doxorubicin—liver cancer	0.000213	0.000377	CcSEcCtD
Bexarotene—Rash—Epirubicin—liver cancer	0.000212	0.000376	CcSEcCtD
Bexarotene—Dermatitis—Epirubicin—liver cancer	0.000212	0.000375	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—SERPINE1—liver cancer	0.000211	0.000487	CbGpPWpGaD
Bexarotene—Headache—Epirubicin—liver cancer	0.000211	0.000373	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000209	0.000481	CbGpPWpGaD
Bexarotene—Dizziness—Doxorubicin—liver cancer	0.000206	0.000364	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—STAT3—liver cancer	0.000206	0.000473	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000203	0.000466	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.0002	0.000461	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.0002	0.000461	CbGpPWpGaD
Bexarotene—Nausea—Epirubicin—liver cancer	0.0002	0.000354	CcSEcCtD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.0002	0.00046	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR1H4—liver cancer	0.000199	0.000458	CbGpPWpGaD
Bexarotene—Vomiting—Doxorubicin—liver cancer	0.000198	0.00035	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000198	0.000455	CbGpPWpGaD
Bexarotene—Rash—Doxorubicin—liver cancer	0.000196	0.000348	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—liver cancer	0.000196	0.000347	CcSEcCtD
Bexarotene—RXRA—Gene Expression—NR1I3—liver cancer	0.000196	0.00045	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000195	0.000449	CbGpPWpGaD
Bexarotene—Headache—Doxorubicin—liver cancer	0.000195	0.000345	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TGFB1—liver cancer	0.000191	0.000438	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000188	0.000434	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000186	0.000429	CbGpPWpGaD
Bexarotene—Nausea—Doxorubicin—liver cancer	0.000185	0.000327	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—CYP2E1—liver cancer	0.000184	0.000424	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000184	0.000423	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000184	0.000422	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.000182	0.000418	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.00018	0.000414	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—liver cancer	0.000178	0.000409	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000175	0.000403	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000175	0.000402	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000174	0.0004	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB1—liver cancer	0.000174	0.0004	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000173	0.000399	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ABL1—liver cancer	0.000171	0.000393	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000169	0.00039	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000169	0.000389	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—CYCS—liver cancer	0.000168	0.000388	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000165	0.00038	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000164	0.000378	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—H2AFX—liver cancer	0.000163	0.000376	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GLUL—liver cancer	0.000161	0.000369	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CPT1B—liver cancer	0.000161	0.000369	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000156	0.000359	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NR1H4—liver cancer	0.000155	0.000356	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—H2AFX—liver cancer	0.000154	0.000354	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000153	0.000351	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTA3—liver cancer	0.000152	0.00035	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000152	0.000349	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.00015	0.000345	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000149	0.000343	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARA—liver cancer	0.000148	0.000341	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000146	0.000337	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARA—liver cancer	0.000145	0.000335	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IL6—liver cancer	0.000144	0.00033	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—liver cancer	0.000142	0.000328	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.00014	0.000323	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.00014	0.000322	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.00014	0.000321	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARA—liver cancer	0.000139	0.000321	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTA4—liver cancer	0.000139	0.00032	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000138	0.000317	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARA—liver cancer	0.000137	0.000315	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000136	0.000313	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HNF4A—liver cancer	0.000136	0.000312	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTA2—liver cancer	0.000136	0.000312	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000135	0.00031	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAPK14—liver cancer	0.000134	0.000309	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—ESR1—liver cancer	0.000134	0.000309	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—liver cancer	0.000134	0.000308	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.000132	0.000304	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ESR1—liver cancer	0.000132	0.000303	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTA1—liver cancer	0.000131	0.000301	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000131	0.000301	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.00013	0.0003	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00013	0.000299	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.00013	0.000299	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KDR—liver cancer	0.00013	0.000298	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NAT2—liver cancer	0.000129	0.000298	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK14—liver cancer	0.000129	0.000296	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MET—liver cancer	0.000127	0.000292	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAPK14—liver cancer	0.000126	0.000291	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000124	0.000286	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALDOB—liver cancer	0.000124	0.000285	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ESR1—liver cancer	0.000124	0.000285	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—liver cancer	0.000122	0.000282	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000121	0.000279	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARG—liver cancer	0.00012	0.000277	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.00012	0.000276	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000119	0.000274	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PSMA4—liver cancer	0.000119	0.000273	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PSMD10—liver cancer	0.000119	0.000273	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CRABP1—liver cancer	0.000118	0.000272	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—PPARA—liver cancer	0.000118	0.000272	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000115	0.000265	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—liver cancer	0.000115	0.000265	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—liver cancer	0.000113	0.00026	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000111	0.000256	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—SERPINE1—liver cancer	0.00011	0.000254	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SERPINE1—liver cancer	0.000108	0.000249	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000107	0.000245	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP2—liver cancer	0.000106	0.000243	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HPGDS—liver cancer	0.000103	0.000238	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000103	0.000237	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SERPINE1—liver cancer	0.000102	0.000234	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.0001	0.00023	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	9.92e-05	0.000228	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UGDH—liver cancer	9.89e-05	0.000228	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	9.88e-05	0.000227	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	9.74e-05	0.000224	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.37e-05	0.000216	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RAF1—liver cancer	9.36e-05	0.000215	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—EPT1—liver cancer	9.3e-05	0.000214	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.25e-05	0.000213	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PSMA4—liver cancer	9.22e-05	0.000212	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PSMD10—liver cancer	9.22e-05	0.000212	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—liver cancer	9.2e-05	0.000212	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	9.08e-05	0.000209	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GOT2—liver cancer	8.97e-05	0.000206	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TAT—liver cancer	8.82e-05	0.000203	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—liver cancer	8.79e-05	0.000202	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP1A1—liver cancer	8.72e-05	0.000201	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	8.67e-05	0.0002	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	8.6e-05	0.000198	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2E1—liver cancer	8.43e-05	0.000194	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.17e-05	0.000188	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CTNNB1—liver cancer	8.11e-05	0.000187	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—H2AFX—liver cancer	8.01e-05	0.000184	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—RAF1—liver cancer	7.95e-05	0.000183	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—liver cancer	7.95e-05	0.000183	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYCS—liver cancer	7.89e-05	0.000182	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GGT1—liver cancer	7.74e-05	0.000178	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GOT1—liver cancer	7.74e-05	0.000178	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—liver cancer	7.14e-05	0.000164	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARA—liver cancer	7.13e-05	0.000164	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—liver cancer	7.07e-05	0.000163	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—liver cancer	6.98e-05	0.00016	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTP1—liver cancer	6.96e-05	0.00016	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMOX1—liver cancer	6.86e-05	0.000158	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—liver cancer	6.85e-05	0.000158	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAPK14—liver cancer	6.58e-05	0.000151	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—liver cancer	6.55e-05	0.000151	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UGDH—liver cancer	6.52e-05	0.00015	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.49e-05	0.000149	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ESR1—liver cancer	6.46e-05	0.000149	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—liver cancer	6.44e-05	0.000148	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—liver cancer	6.39e-05	0.000147	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—EPT1—liver cancer	6.13e-05	0.000141	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—liver cancer	6.12e-05	0.000141	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KRAS—liver cancer	6.07e-05	0.00014	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1A1—liver cancer	6.06e-05	0.000139	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CPT1B—liver cancer	5.99e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GLUL—liver cancer	5.99e-05	0.000138	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—liver cancer	5.89e-05	0.000136	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TAT—liver cancer	5.82e-05	0.000134	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NR1H4—liver cancer	5.78e-05	0.000133	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA3—liver cancer	5.68e-05	0.000131	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—liver cancer	5.65e-05	0.00013	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARA—liver cancer	5.54e-05	0.000128	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—liver cancer	5.31e-05	0.000122	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA4—liver cancer	5.2e-05	0.00012	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HRAS—liver cancer	5.16e-05	0.000119	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.08e-05	0.000117	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA2—liver cancer	5.06e-05	0.000117	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.98e-05	0.000115	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—liver cancer	4.94e-05	0.000114	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA1—liver cancer	4.89e-05	0.000112	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NAT2—liver cancer	4.83e-05	0.000111	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—liver cancer	4.75e-05	0.000109	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CG—liver cancer	4.75e-05	0.000109	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.65e-05	0.000107	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDOB—liver cancer	4.63e-05	0.000107	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—liver cancer	4.58e-05	0.000105	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—liver cancer	4.55e-05	0.000105	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—liver cancer	4.47e-05	0.000103	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CRABP1—liver cancer	4.42e-05	0.000102	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CD—liver cancer	4.17e-05	9.6e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—liver cancer	4.12e-05	9.48e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.98e-05	9.15e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GLUL—liver cancer	3.95e-05	9.1e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CPT1B—liver cancer	3.95e-05	9.1e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HPGDS—liver cancer	3.86e-05	8.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.84e-05	8.83e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NR1H4—liver cancer	3.81e-05	8.77e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA3—liver cancer	3.75e-05	8.62e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CB—liver cancer	3.64e-05	8.37e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.5e-05	8.05e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.45e-05	7.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PSMA4—liver cancer	3.44e-05	7.92e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PSMD10—liver cancer	3.44e-05	7.92e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA4—liver cancer	3.43e-05	7.89e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—liver cancer	3.36e-05	7.73e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT2—liver cancer	3.35e-05	7.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA2—liver cancer	3.34e-05	7.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA1—liver cancer	3.22e-05	7.41e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAT2—liver cancer	3.19e-05	7.33e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2E1—liver cancer	3.15e-05	7.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDOB—liver cancer	3.05e-05	7.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.05e-05	7.01e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYCS—liver cancer	2.95e-05	6.78e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CRABP1—liver cancer	2.91e-05	6.71e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT1—liver cancer	2.89e-05	6.65e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GGT1—liver cancer	2.89e-05	6.65e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—liver cancer	2.6e-05	5.97e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—liver cancer	2.56e-05	5.89e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HPGDS—liver cancer	2.55e-05	5.86e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—liver cancer	2.39e-05	5.49e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—liver cancer	2.33e-05	5.36e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSMA4—liver cancer	2.27e-05	5.22e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSMD10—liver cancer	2.27e-05	5.22e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1A1—liver cancer	2.26e-05	5.2e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—liver cancer	2.22e-05	5.1e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT2—liver cancer	2.21e-05	5.08e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—liver cancer	2.11e-05	4.85e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2E1—liver cancer	2.08e-05	4.78e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARA—liver cancer	2.07e-05	4.76e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYCS—liver cancer	1.94e-05	4.47e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GGT1—liver cancer	1.91e-05	4.39e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT1—liver cancer	1.91e-05	4.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.86e-05	4.28e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—liver cancer	1.81e-05	4.17e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CG—liver cancer	1.77e-05	4.08e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—liver cancer	1.71e-05	3.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—liver cancer	1.71e-05	3.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—liver cancer	1.69e-05	3.89e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—liver cancer	1.57e-05	3.62e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CD—liver cancer	1.56e-05	3.58e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—liver cancer	1.54e-05	3.54e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1A1—liver cancer	1.49e-05	3.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—liver cancer	1.39e-05	3.2e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARA—liver cancer	1.36e-05	3.14e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CB—liver cancer	1.36e-05	3.12e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CG—liver cancer	1.17e-05	2.69e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—liver cancer	1.13e-05	2.59e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CD—liver cancer	1.03e-05	2.36e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—liver cancer	1.01e-05	2.33e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CB—liver cancer	8.95e-06	2.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—liver cancer	8.28e-06	1.9e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—liver cancer	6.76e-06	1.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—liver cancer	5.46e-06	1.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—liver cancer	4.46e-06	1.03e-05	CbGpPWpGaD
